Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Home Based Primary Care for Patients with Sickle Cell Disease

Mikaela D Moore, BS, Andrew Schamess, MD, Nita Williams, BS, Ying Huang, MA, MS, Gifty Menka, RN, Payal C Desai, MD

Blood (2018) 132 (Supplement 1): 4721.

https://doi.org/10.1182/blood-2018-99-120040

Published: 2018

Journal Articles

Our Hands, Our Health: Developing a Promising Group Healthcare Model for Pediatric to Adult Transition in a Sickle Cell Disease Clinic

Angela Rivers, MD, Ronisha Edwards, MSW, Divya Bhandar, Sharice Bradford, EdD, Brigid Packer, APRN, CNP, Robin Johnson, DNP, APN, CPNP, Nicole Rodos, CPNPAC, DNP, Susan Walsh, DNP, CPNP, Patil Crystal, PhD

Blood (2018) 132 (Supplement 1): 4713.

https://doi.org/10.1182/blood-2018-99-111848

Published: 2018

Journal Articles

Patient Adherence and Persistence to Oral Targeted Therapies for Hematologic Malignancies: A Retrospective Cohort Study Among Managed Care Enrollees

Krish Patel, MD, Vinjamuri Sai Sudhir, Shaum Kabadi, PhD MPH, Joanna C Huang, PharmD, Sanchita Porwal, BS, Kushan Thakkar, MS, John M. Pagel, MD PhD

Blood (2018) 132 (Supplement 1): 3534.

https://doi.org/10.1182/blood-2018-99-112820

Published: 2018

Journal Articles

A Pilot Intervention to Improve Hydroxyurea Adherence in Youth with Sickle Cell Disease through Community Health Workers: The "Habit" Study

Nancy S. Green, MD, Deepa Manwani, MD, Luisa Soto, BA, Yina Castillo, AA, Karen Ireland, BA, Zhezhen Jin, PhD, Arlene Smaldone, PhD CPNP

Blood (2016) 128 (22): 1310.

https://doi.org/10.1182/blood.V128.22.1310.1310

Published: 2016

Journal Articles

The Feasibility of a Telemedicine Platform to Monitor Adherence and Adverse Effects of ABL Kinase Inhibitors

Anureet Copeland, MD, Robert Wehbie, MDPhD, Monique Clayton, Anderson Black, Barbara Rapchak, Matthew C Foster, MD

Blood (2015) 126 (23): 3308.

https://doi.org/10.1182/blood.V126.23.3308.3308

Published: 2015

Journal Articles

Hydroxyurea Adherence By Personal Best HbF and the 2-Site “HABIT” Intervention Trial for Pediatric Sickle Cell Disease

Nancy S. Green, MD, Deepa Manwani, MD, Luisa Soto, BS, Ireland Karen, Yina Castillo, BA (pending), Arlene M. Smaldone, DNSc, CPNP

Blood (2014) 124 (21): 1383.

https://doi.org/10.1182/blood.V124.21.1383.1383

Published: 2014

Journal Articles

Cardiac Iron Overload In Sickle-Cell Disease

Antonella Meloni, PhD, Mammen Puliyel, M.B., B.S., Alessia Pepe, MD, PhD, Massimo Lombardi, MD, Vasilios Berdoukas, MB, BS, Thomas D. Coates, MD, John C Wood, MD, PhD

Blood (2013) 122 (21): 1013.

https://doi.org/10.1182/blood.V122.21.1013.1013

Published: 2013

Journal Articles

Persistence Among Patients with Non-Valvular Atrial Fibrillation Beginning Dabigatran or Warfarin

Kevin M Francis, Kimberly Siu, MD, MPH, Chen Yu, Hasmik Alvrtsyan, MS, Yajing Rao, MS, David R Walker, PhD, Stephen D Sander, PharmD, Martin Zalesak, M.D., Ph.D., Gavin Miyasato, MS, Herman Sanchez, MBA

Blood (2012) 120 (21): 365.

https://doi.org/10.1182/blood.V120.21.365.365

Published: 2012

Journal Articles

Mobile Directly Observed Therapy: Monitoring and Improving Hydroxyurea Adherence in Pediatric Sickle Cell Patients

Susan E. Creary, MD, Mark T Gladwin, MD, Lakshmanan Krishnamurti, MD

Blood (2012) 120 (21): 2060.

https://doi.org/10.1182/blood.V120.21.2060.2060

Published: 2012

Journal Articles

Preoperative Hemoglobin Levels, Characteristics, and Resource Utilization in Total Knee Replacement Patients with An Anemia Diagnosis Versus without An Anemia Diagnosis: An Electronic Medical Record Analysis

Jamie B. Forlenza, PharmD, MS, Lorie Ellis, PhD, Helene Parise, MA, Marie-Hélène Lafeuille, MA, Patrick Lefebvre, MA

Blood (2011) 118 (21): 2089.

https://doi.org/10.1182/blood.V118.21.2089.2089

Published: 2011

Journal Articles

Preoperative Hemoglobin Levels, Characteristics, and Resource Utilization in Total Hip Replacement Patients with An Anemia Diagnosis Versus without An Anemia Diagnosis: An Electronic Medical Record Analysis

Jamie B. Forlenza, PharmD, MS, Lorie Ellis, PhD, Helene Parise, MA, Marie-Hélène Lafeuille, MA, Patrick Lefebvre, MA

Blood (2011) 118 (21): 4748.

https://doi.org/10.1182/blood.V118.21.4748.4748

Published: 2011

Journal Articles

Costs, Persistence, and Hospitalizations Associated with the Use of Iron-Chelating Therapies in Sickle Cell Disease in Medicaid Patients

Edward P Armstrong, Pharm.D, Grant H Skrepnek, PhD, Samir K. Ballas, MD, Peter Kwok, Pharm.D, Susan Snodgrass, MD, Medha Sasane, PhD

Blood (2011) 118 (21): 3152.

https://doi.org/10.1182/blood.V118.21.3152.3152

Published: 2011

Journal Articles

A Global Retrospective and Physician-Based Analysis of Adherence to Tyrosine Kinase Inhibitor (TKI) Therapies for Chronic Myeloid Leukemia (CML).

François Guilhot, MD, John Coombs, PharmD, MBA, Oleg Zernovak, MD, Tomasz Szczudlo, Gianantonio Rosti

Blood (2010) 116 (21): 1514.

https://doi.org/10.1182/blood.V116.21.1514.1514

Published: 2010

Journal Articles

Adherence with Hydroxyurea in Children with Sickle Cell Disease

Courtney D. Thornburg, MD, MS, Agustin Calatroni, MS, Brittany Herzberg, Marilyn J. Telen, MD, Alex Kemper, MD, MPH, MS

Blood (2008) 112 (11): 167.

https://doi.org/10.1182/blood.V112.11.167.167

Published: 2008

Journal Articles

Hydroxyurea Use in Sickle Cell Disease Patients in a Florida Medicaid Population.

Jane N. Ritho, PharmD, Dionne Y. Mayhew, PhD, Abraham G. Hartzema, PhD, Huazhi Liu, MS, Richard Lottenberg, MD

Blood (2007) 110 (11): 79.

https://doi.org/10.1182/blood.V110.11.79.79

Published: 2007

NARROW

Home Based Primary Care for Patients with Sickle Cell Disease

Our Hands, Our Health: Developing a Promising Group Healthcare Model for Pediatric to Adult Transition in a Sickle Cell Disease Clinic

Patient Adherence and Persistence to Oral Targeted Therapies for Hematologic Malignancies: A Retrospective Cohort Study Among Managed Care Enrollees

A Pilot Intervention to Improve Hydroxyurea Adherence in Youth with Sickle Cell Disease through Community Health Workers: The "Habit" Study

The Feasibility of a Telemedicine Platform to Monitor Adherence and Adverse Effects of ABL Kinase Inhibitors

Hydroxyurea Adherence By Personal Best HbF and the 2-Site “HABIT” Intervention Trial for Pediatric Sickle Cell Disease

Cardiac Iron Overload In Sickle-Cell Disease

Persistence Among Patients with Non-Valvular Atrial Fibrillation Beginning Dabigatran or Warfarin

Mobile Directly Observed Therapy: Monitoring and Improving Hydroxyurea Adherence in Pediatric Sickle Cell Patients

Preoperative Hemoglobin Levels, Characteristics, and Resource Utilization in Total Knee Replacement Patients with An Anemia Diagnosis Versus without An Anemia Diagnosis: An Electronic Medical Record Analysis

Preoperative Hemoglobin Levels, Characteristics, and Resource Utilization in Total Hip Replacement Patients with An Anemia Diagnosis Versus without An Anemia Diagnosis: An Electronic Medical Record Analysis

Costs, Persistence, and Hospitalizations Associated with the Use of Iron-Chelating Therapies in Sickle Cell Disease in Medicaid Patients

A Global Retrospective and Physician-Based Analysis of Adherence to Tyrosine Kinase Inhibitor (TKI) Therapies for Chronic Myeloid Leukemia (CML).

Adherence with Hydroxyurea in Children with Sickle Cell Disease

Hydroxyurea Use in Sickle Cell Disease Patients in a Florida Medicaid Population.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only